November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Novel MRI Technique Measures Amino Acid Transport in Preclinical Cancer Models

🏥 Public Health 2 min read 👁 3

Johns Hopkins researchers have demonstrated an advanced MRI method that uses alanine uptake to measure the activity of the ASCT2 cancer biomarker in animal models.

🏥Public Health

Key points

  • Johns Hopkins researchers developed ALAwCEST MRI to measure active alanine uptake in cancer models.
  • The technique successfully identified higher ASCT2 transporter activity in pancreatic and prostate tumor models.
  • The research is currently limited to preclinical animal models and requires human clinical trials.

A research team at Johns Hopkins University has demonstrated a non-invasive imaging method capable of tracking functional biomarker activity in tumor models, according to a study published in Nature Health Sciences. The approach, known as alanine-weighted chemical exchange saturation transfer (ALAwCEST) magnetic resonance imaging, measures how cancer cells absorb the amino acid alanine via the alanine-serine-cysteine transporter 2 (ASCT2) protein.

In laboratory experiments using mouse xenograft models, intravenous administration of alanine produced distinct contrast enhancement on MRI scans that directly mirrored functional ASCT2 levels. In pancreatic cancer models engineered to overexpress the transporter, signal enhancement was significantly higher than in standard control tumors (p < 0.0001). The technique also effectively distinguished between different human prostate tumor lines based on their transporter content and metabolic activity.

What to know: Conventional diagnostic methods rely on tissue samples to check for the presence of the ASCT2 protein, but protein expression does not always reflect active amino acid uptake. While this imaging approach could eventually help monitor metabolic activity in tumors, the current findings are limited to early-stage animal models. Further clinical studies are required to establish whether the method is safe and effective for human patients. Readers seeking medical advice regarding cancer screening or treatment should consult a qualified physician.

Source Nature Health Sciences — nature.com/articles/s44303-026-00217-z ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.